2-甲基丙脒 | 57536-10-4

• 物质功能分类: 有机原料 - 氨基化合物 - 无环单胺、多胺及其衍生物和盐
• 分子结构分类: 有机化合物 - 有机氮化合物
• 中文名称: 2-甲基丙脒
• 中文别名: 2-甲基丙胺酰亚胺盐酸盐；异丁脒盐酸盐；盐酸异丁脒；盐酸异丙基胍
• 英文名称: isobutyramidine
• 英文别名: isobutyrimidamide；isopropylcarbamidine；2-Methylpropanimidamide
• CAS: 57536-10-4
• 化学式: C₄H₁₀N₂
• mdl: MFCD00939260
• 分子量: 86.1368
• InChiKey: NDAJNMAAXXIADY-UHFFFAOYSA-N

物化性质

• 沸点：
  105-107 °C(Press: 20 Torr)
• 密度：
  0.97±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.3
• 重原子数：
  6
• 可旋转键数：
  1
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.75
• 拓扑面积：
  49.9
• 氢给体数：
  2
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  2-甲基丙脒 在 水 作用下， 生成 异丁酰胺
  参考文献：
  名称：

  Acylations of Nitriles with Esters by Sodium Amide in Liquid Ammonia to Form β-Ketonitriles. Consideration of Amidine Formation¹

  摘要：

  DOI：

  10.1021/ja01560a060
• 作为产物：
  描述：

  异丁腈 在 氨 、 溴化铵 作用下， 生成 2-甲基丙脒
  参考文献：
  名称：

  Preparation of Amidine Salts by Reaction of Nitriles with Ammonium Salts in the Presence of Ammonia

  摘要：

  DOI：

  10.1021/jo01051a033

文献信息

• Regioselective synthesis of pyrimido[5,4-c][2,1]benzothiazines by reactions of β-chloroaldehydes with n-c-n binucleophiles
  作者：Kirill Popov、Tatyana Volovnenko、Alexander Turov、Yulian Volovenko

  DOI：10.1002/jhet.271

  日期：——

  The method of pyrimidine ring fusion at the [c] side of benzothiazines based on the reaction of their chloroaldehyde derivatives with amidines is described. Formation of the structural isomers of reaction products was investigated, and regioselectivity of heterocyclization reactions was shown. A number of novel pyrimidobenzothiazines were synthesized. J. Heterocyclic Chem., 2010.

  描述了基于苯并噻嗪的氯醛衍生物与am的反应在嘧啶环的[ c ]侧进行嘧啶环稠合的方法。研究了反应产物的结构异构体的形成，并显示了杂环化反应的区域选择性。合成了许多新颖的嘧啶并苯并噻嗪。J.杂环化​​学.2010。
• [EN] HETEROCYCLIC COMPOUNDS AND COMPOSITIONS AS C-KIT AND PDGFR KINASE INHIBITORS<br/>[FR] COMPOSÉS ET COMPOSITIONS HÉTÉROCYCLIQUES COMME INHIBITEURS DE C-KIT ET PDGFR KINASE
  申请人：IRM LLC

  公开号：WO2009105712A1

  公开（公告）日：2009-08-27

  The invention provides a novel class of compounds of Formula I: (I) pharmaceutical compositions comprising such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of c-kit, PDGFRα and PDGFRβ kinases.

  这项发明提供了一类新型的化合物，其化学式为：(I) 制备包含这类化合物的药物组合物，用于治疗或预防与异常或失调的激酶活性相关的疾病或紊乱，特别是涉及c-kit、PDGFRα和PDGFRβ激酶异常活化的疾病或紊乱。
• [EN] PROTEIN KINASE INHIBITORS<br/>[FR] INHIBITEURS DE PROTÉINES KINASES
  申请人：PHARMASCIENCE INC

  公开号：WO2015077866A1

  公开（公告）日：2015-06-04

  The present invention relates to a novel family of protein kinase inhibitors, more specifically the present invention is directed to inhibitors of the members of the Tec or Src protein kinase families. The present invention also relates to processes for the preparation of these compounds, to the pharmaceutical composition comprising them, and to their use in the treatment of proliferative, inflammatory, infectious or autoimmune diseases, disorder or condition in which protein kinase activity is implicated. More particularly, the present invention relates to a compound of Formula I.

  本发明涉及一种新型蛋白激酶抑制剂家族，更具体地说，本发明是针对Tec或Src蛋白激酶家族成员的抑制剂。本发明还涉及制备这些化合物的方法，包括含有它们的药物组合物，以及它们在治疗蛋白激酶活性参与的增殖性、炎症性、感染性或自身免疫疾病、紊乱或病症中的用途。更具体地说，本发明涉及一种I式化合物。
• 2-Benzazepines. 5. Synthesis of pyrimido[5,4-d][2]benzazepines and their evaluation as anxiolytic agents
  作者：Eugene J. Trybulski、Louis E. Benjamin、James V. Earley、R. Ian Fryer、Norman W. Gilman、Earl Reeder、Armin Walser、Arnold B. Davidson、W. Dale Horst

  DOI：10.1021/jm00365a008

  日期：1983.11

  A series of 5H-pyrimido[5,4-d][2]benzazepines has been synthesized, starting from the corresponding 2-benzazepin-5-ones, and evaluated as potential anxiolytic agents. Selected compounds from this series show a pharmacological profile of action different than that of diazepam. They are more potent than diazepam in the anti-pentylenetetrazole test and in the [3H]diazepam binding assay, yet show less

  从相应的2-苯并ze庚因-5-酮开始，合成了一系列5H-嘧啶并[5,4-d] [2]苯并ze庚因，并被评估为潜在的抗焦虑药。从该系列中选择的化合物显示出与地西epa不同的药理作用。在抗戊烯四唑试验和[3H]地西ze结合试验中，它们比地西epa更有效，但在斜筛试验中却显示出较小的活​​性。给出了9-氯-7-（2-氯苯基）-5H-嘧啶[5,4-d] [2]苯并ze庚因（7c）的药理数据。讨论了这些潜在抗焦虑剂的构效关系。
• CuI-Catalyzed Amination of Arylhalides with Guanidines or Amidines: A Facile Synthesis of 1-<i>H</i>-2-Substituted Benzimidazoles
  作者：Xiaohu Deng、Heather McAllister、Neelakandha S. Mani

  DOI：10.1021/jo900912h

  日期：2009.8.7

  CuI/L5 (N,N′-dimethylethylenediamine) proves to be an efficient catalyst system for the amination of arylhalides with guanidines. The same catalyst system is then successfully applied to the one-step synthesis of 1-H-2-amino-benzimidazoles through tandem aminations of 1,2-dihaloarenes in modest yields. This methodology is also applicable for the preparation of 1-H or 1-substutituted 2-aryl- or 2-alkyl-benzimidazoles

  事实证明，CuI / L5（N，N'-二甲基乙二胺）是一种用于将芳基卤化物与胍胺化的有效催化剂体系。然后将相同的催化剂体系成功地通过1,2-二卤代芳烃的串联胺化以适度的产率成功地一步合成1- H -2-氨基-苯并咪唑。该方法学也可用于制备1- H或1-取代的2-芳基-或2-烷基-苯并咪唑。